or Try an Advanced Search...

    Technical Analysis for APVO - Aptevo Therapeutics Inc.

    Grade Last Price % Change Price Change
    C 0.27 -6.14% -0.02
    APVO closed up 16.05 percent on Wednesday, November 20, 2024, on 1.51 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Up
    Historical APVO trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish -6.14%
    Expansion Pivot Buy Setup Bullish Swing Setup -6.14%
    Pocket Pivot Bullish Swing Setup -6.14%
    Spinning Top Other -6.14%
    Wide Range Bar Range Expansion -6.14%
    Wide Bands Range Expansion -6.14%
    Gapped Up Strength -6.14%
    Up 3 Days in a Row Strength -6.14%
    Upper Bollinger Band Touch Strength -6.14%
    Crossed Above 50 DMA Bullish 8.92%
    Older End-of-Day Signals for APVO ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 2 hours ago
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    Rose Above 20 DMA about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    APVO Chart by TradingView
    Basic chart:

    Profile

    Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Hematology

    Is APVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
    Oct 29 Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Sep 18 Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 17 Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Sep 17 Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 16 Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
    Sep 13 Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
    Aug 30 Aptevo Therapeutics files to sell 13.51M shares of common stock
    Aug 8 Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
    See more APVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.8
    52 Week Low 0.138
    Average Volume 8,474,483
    200-Day Moving Average 1.55
    50-Day Moving Average 0.22
    20-Day Moving Average 0.26
    10-Day Moving Average 0.26
    Average True Range 0.05
    RSI (14) 56.52
    ADX 53.01
    +DI 38.04
    -DI 11.49
    Chandelier Exit (Long, 3 ATRs) 0.37
    Chandelier Exit (Short, 3 ATRs) 0.34
    Upper Bollinger Bands 0.31
    Lower Bollinger Band 0.21
    Percent B (%b) 0.77
    BandWidth 39.86
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0023
    Fundamentals Value
    Market Cap 6.48 Million
    Num Shares 22.3 Million
    EPS -2.44
    Price-to-Earnings (P/E) Ratio -0.12
    Price-to-Sales 1.61
    Price-to-Book 0.24
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.44
    Resistance 3 (R3) 0.44 0.38 0.42
    Resistance 2 (R2) 0.38 0.34 0.38 0.41
    Resistance 1 (R1) 0.34 0.32 0.36 0.34 0.40
    Pivot Point 0.28 0.28 0.29 0.28 0.28
    Support 1 (S1) 0.23 0.24 0.26 0.24 0.18
    Support 2 (S2) 0.18 0.22 0.18 0.17
    Support 3 (S3) 0.13 0.18 0.16
    Support 4 (S4) 0.14